Pill imprint 2327 V has been identified as Benztropine mesylate 2 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 2 mg is not subject to the Controlled Substances Act.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.